BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8985208)

  • 1. Alteration of interleukin-2 (IL-2) and soluble IL-2 receptor secretion in the sera and urine of patients with rickettsial boutonneuse fever.
    Mansueto S; D'Ancona FP; Colletti P; Graceffa R; La Seta F; Pecoraro V; Gambino G; Grillo G; Vitale G; Richiusa P; D'Agostino P; Cillari E
    J Infect Dis; 1997 Jan; 175(1):142-5. PubMed ID: 8985208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients.
    Vitale G; Reina G; Mansueto S; Malta R; Gambino G; Mocciaro C; D'Agostino R; Dieli M; Cillari E
    Clin Exp Immunol; 1992 Nov; 90(2):219-22. PubMed ID: 1424277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
    Symons JA; Wood NC; Di Giovine FS; Duff GW
    J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of luteinizing hormone alpha-subunit on IL-2 and sIL-2R in vitro secretions from human peripheral blood mononuclear cells.
    Komorowski J; Gradowski G; Stepień H
    Cytobios; 1997; 89(356):31-7. PubMed ID: 9297814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute phase response in Sicilian patients with boutonneuse fever admitted to hospitals in Palermo, 1992-1997.
    Vitale G; Mansueto S; Gambino G; Mocciaro C; Spinelli A; Rini GB; Affronti M; Chifari N; La Russa C; Di Rosa S; Colletti P; Barbera C; La Rosa M; Di Bella G; Ferlazzo V; Milano S; D'Agostino P; Cillari E
    J Infect; 2001 Jan; 42(1):33-9. PubMed ID: 11243751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-12 in human boutonneuse fever caused by Rickettsia conorii.
    Milano S; D'Agostino P; Di Bella G; La Rosa M; Barbera C; Ferlazzo V; Mansueto P; Rini GB; Barera A; Vitale G; Mansueto S; Cillari E
    Scand J Immunol; 2000 Jul; 52(1):91-5. PubMed ID: 10886788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.
    Mansueto S; Vitale G; Mocciaro C; Gambino G; Colletti P; Mansueto P; Spinelli A; Affronti M; Chifari N; Arcoleo F; Milano S; Cillari E
    Clin Exp Immunol; 1998 Mar; 111(3):555-8. PubMed ID: 9528898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of verapamil on the IL-2 binding to its active receptor and on the release of IL-2 receptor by activated PBMC.
    Mikhail N; Raska K; Raskova J; Degiannis D
    Immunopharmacology; 1993; 25(1):29-36. PubMed ID: 8320080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease.
    Damle RN; Advani SH; Gangal SG
    Int J Cancer; 1992 Jan; 50(2):192-6. PubMed ID: 1730512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
    Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
    J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tumor-associated macrophages on serum soluble IL-2R levels in B-cell lymphomas.
    Sakai A; Yoshida N
    J Clin Exp Hematop; 2014; 54(1):49-57. PubMed ID: 24942946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis.
    Famularo G; Procopio A; Giacomelli R; Danese C; Sacchetti S; Perego MA; Santoni A; Tonietti G
    Clin Exp Immunol; 1990 Sep; 81(3):368-72. PubMed ID: 2397608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
    Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
    Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells.
    Zorn U; Dallmann I; Grosse J; Kirchner H; Poliwoda H; Atzpodien J
    Cytokine; 1994 Jul; 6(4):358-64. PubMed ID: 7948742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer.
    De Vita F; Turitto G; di Grazia M; Frattolillo A; Catalano G
    Tumori; 1998; 84(1):33-8. PubMed ID: 9619711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hCG and beta-hCG on IL-2 and sIL-2R secretion from human peripheral blood mononuclear cells: a dose-response study in vitro.
    Komorowski J; Gradowski G; Stepień H
    Immunol Lett; 1997 Oct; 59(1):29-33. PubMed ID: 9334854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
    Peter JB; Boctor FN; Tourtellotte WW
    Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.